300. IgG4-related disease Clinical trials / Disease details
Clinical trials : 40 / Drugs : 47 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 141
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02899039 (ClinicalTrials.gov) | July 2012 | 2/9/2016 | Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease | Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease | IgG4-related Disease | Biological: extra blood draw samples | Assistance Publique Hopitaux De Marseille | NULL | Completed | 18 Years | N/A | Both | 75 | N/A | France |